CDH13 and prostate carcinoma: Low CDH13 expression is associated with poor prognosis in various cancers, such as lung, ovarian, cervical, and prostate cancer.13 Notably, we found that the expression of CDH13 was strongly upregulated in patients with ACC, and low expression was related to a good prognosis in ACC patients.